Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.23.1
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Other $ 3,080 $ 2,750
Total accrued expenses and other current liabilities 14,764 8,402
Supply Agreement | Vaxcyte    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration and license agreements and supply agreement accruals 4,830 2,286
CMO    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration and license agreements and supply agreement accruals 3,900 1,102
Clinical Trials    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration and license agreements and supply agreement accruals $ 2,954 $ 2,264